Masanori Matsumoto

25PUBLICATIONS
68CO-AUTHORS
Adolescent healthAutoimmunityHaematologyRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 11, 2026
Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

|Jun 23, 2026
Critical ischemia of multiple organ systems in a patient with systemic lupus erythematosus complicated by catastrophic antiphospholipid syndrome: Potential pathogenetic role of non-inhibitory anti-ADAMTS13 autoantibodies.

|Feb 25, 2026
Impact of haemoglobin vesicles on pretransfusion testing and mitigation strategies.

Kazuto Omae, Kazuya Sakai, Hiroaki Tanaka

|Mar 16, 2025
Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data.

Kazuya Sakai, Atsushi Hamamura, Yoshiko Yoshimura

|Feb 22, 2024
Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP.

Kenki Saito, Kazuya Sakai, Masayuki Kubo

|Sep 09, 2023
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.

Masanori Matsumoto, Yoshitaka Miyakawa, Koichi Kokame

Pageof 5

Frequent Collaborators

9 joint publications

Kazuya Sakai

4 joint publications

Bernhard Lämmle

4 joint publications

Kenki Saito

3 joint publications

Paul N Knöbl